Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease

Brain

Volumn 135, Issue 5, 2012, Pages 1478-1485

  Arai, Eiji ^a   Arai, Makoto ^a   Uchiyama, Tomoyuki ^a   Higuchi, Yoshinori ^a   Aoyagi, Kyoko ^a   Yamanaka, Yoshitaka ^a   Yamamoto, Tatsuya ^a   Nagano, Osamu ^a   Shiina, Akihiro ^a   Maruoka, Daisuke ^a   Matsumura, Tomoaki ^a   Nakagawa, Tomoo ^a   Katsuno, Tatsuro ^a   Imazeki, Fumio ^a   Saeki, Naokatsu ^a   Kuwabara, Satoshi ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

body weight; deep brain stimulation; gastric emptying; ghrelin; Parkinson's disease

Indexed keywords

DECARBOXYLASE INHIBITOR; GHRELIN; LEVODOPA; UREA C 13;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; BREATH ANALYSIS; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; STOMACH EMPTYING; SUBTHALAMIC DEEP BRAIN STIMULATION;

EID: 84860602127     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws086     Document Type: Article

References (65)

1. Arai M, Matsumura T, Tsuchiya N, Sadakane C, Inami R, Suzuki T, et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology 2012; 59: 62-6.
2. Arai N, Yokochi F, Ohnishi T, Momose T, Okiyama R, Taniguchi M, et al. Mechanisms of unilateral STN-DBS in patients with Parkinson's disease: a PET study. J Neurol 2008; 255: 1236-43.
3. Barichella M, Marczewska AM, Mariani C, Landi A, Vairo A, Pezzoli G. Body weight gain rate in patients with Parkinson's disease and deep brain stimulation. Mov Disord 2003; 18: 1337-40.
4. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009; 8: 67-81.
5. Benedetti F, Colloca L, Lanotte M, Bergamasco B, Torre E, Lopiano L. Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region. Brain Res Bull 2004; 63: 203-11.
6. Berkowitz DM, McCallum RW. Interaction of levodopa and metoclopramide on gastric emptying. Clin Pharmacol Ther 1980; 27: 414-20.
7. Canteras NS, Shammah-Lagnado SJ, Silva BA, Ricardo JA. Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res 1990; 513: 43-59.
8. CarrióI, Notivol RI, Celdrán E, Alami M, Subias S, Vilardell F. Interaction of clebopride and levodopa on gastric emptying evaluated using Technetium99-labelled meal in volunteers. Cur Ther Res 1982; 31: S45-S52.
9. Casellas F, Lopez J, Borruel N, Saperas E, Vergara M, de Torres I, et al. The impact of delaying gastric emptying by either meal substrate or drug on the [13C]-urea breath test. Am J Gastroenterol 1999; 94: 369-73.
10. Cersosimo MG, Benarroch EE. Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord 2008; 23: 1065-75.
11. Chapman MJ, Besanko LK, Burgstad CM, Fraser RJ, Bellon M, O'Connor S, et al. Gastric emptying of a liquid nutrient meal in the critically ill: relationship between scintigraphic and carbon breath test measurement. Gut 2011; 60: 1336-43.
12. Corcuff JB, Krim E, Tison F, Foubert-Sanier A, Guehl D, Burbaud P, et al. Subthalamic nucleus stimulation in patients with Parkinson's disease does not increase serum ghrelin levels. Br J Nutr 2006; 95: 1028-9.
13. Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H. Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002; 61: 413-26.
14. Derost PP, Ouchchane L, Morand D, Ulla M, Llorca PM, Barget M, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 2007; 68: 1345-55.
15. Djaldetti R, Baron J, Ziv I, Melamed E. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology 1996; 46: 1051-4.
16. Fiszer U, Michalowska M, Baranowska B, Wolinska-Witort E, Jeske W, Jethon M, et al. Leptin and ghrelin concentrations and weight loss in Parkinson's disease. Acta Neurol Scand 2010; 121: 230-6.
17. Ford B, Winfield L, Pullman SL, Frucht SJ, Du Y, Greene P, et al. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up. J Neurol Neurosurg Psychiatry 2004; 75: 1255-9.
18. Fraix V, Houeto JL, Lagrange C, Le Pen C, Krystkowiak P, Guehl D, et al. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 443-9.
19. Goetze O, Wieczorek J, Mueller T, Przuntek H, Schmidt WE, Woitalla D. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test. Neurosci Lett 2005; 375: 170-3.
20. Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 2001; 16: 1041-7.
21. Herzog J, Volkmann J, Krack P, Kopper F, Potter M, Lorenz D, et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord 2003; 18: 1332-7.
22. Herzog J, Weiss PH, Assmus A, Wefer B, Seif C, Braun PM, et al. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease. Brain 2006; 129 (Pt 12): 3366-75.
23. Herzog J, Weiss PH, Assmus A, Wefer B, Seif C, Braun PM, et al. Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation. Brain 2008; 131 (Pt 1): 132-45.
24. Holmberg B, Corneliusson O, Elam M. Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: no effects on, and of, autonomic dysfunction. Mov Disord 2005; 20: 976-81.
25. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.
26. Hwynn N, Ul Haq I, Malaty IA, Resnick AS, Dai Y, Foote KD, et al. Effect of deep brain stimulation on Parkinson's nonmotor symptoms following unilateral DBS: a pilot study. Parkinsons Dis 2011; 2011: 507416
27. Jost WH. Gastrointestinal dysfunction in Parkinson's disease. J Neurol Sci 2010; 289: 69-73.
28. Klein J, Soto-Montenegro ML, Pascau J, Gunther L, Kupsch A, Desco M, et al. A novel approach to investigate neuronal network activity patterns affected by deep brain stimulation in rats. J Psychiatr Res 2011; 45: 927-30.
29. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.
30. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-34.
31. Krygowska-Wajs A, Cheshire WP Jr., Wszolek ZK, Hubalewska-Dydejczyk A, Jasinska-Myga B, Farrer MJ, et al. Evaluation of gastric emptying in familial and sporadic Parkinson disease. Parkinsonism Relat Disord 2009; 15: 692-6.
32. Ladabaum U, Minoshima S, Hasler WL, Cross D, Chey WD, Owyang C. Gastric distention correlates with activation of multiple cortical and subcortical regions. Gastroenterology 2001; 120: 369-76.
33. Limousin P, Greene J, Pollak P, Rothwell J, Benabid AL, Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol 1997; 42: 283-91.
34. Ludwig J, Remien P, Guballa C, Binder A, Binder S, Schattschneider J, et al. Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 742-5.
35. Mann JM, Foote KD, Garvan CW, Fernandez HH, Jacobson CE IV, Rodriguez RL, et al. Brain penetration effects of microelectrodes and DBS leads in STN or GPi. J Neurol Neurosurg Psychiatry 2009; 80: 794-7.
36. Matsumura T, Arai M, Yonemitsu Y, Maruoka D, Tanaka T, Suzuki T, et al. The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol 2010; 45: 300-7.
37. McCallum RW. Review of the current status of prokinetic agents in gastroenterology. Am J Gastroenterol 1985; 80: 1008-16.
38. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004; 127: 1329-37.
39. Montaurier C, Morio B, Bannier S, Derost P, Arnaud P, Brandolini-Bunlon M, et al. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. Brain 2007; 130 (Pt 7): 1808-18.
40. Murray CD, Martin NM, Patterson M, Taylor SA, Ghatei MA, Kamm MA, et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005; 54: 1693-8.
41. Nagahata Y, Azumi Y, Kawakita N, Wada T, Saitoh Y. Inhibitory effect of dopamine on gastric motility in rats. Scand J Gastroenterol 1995; 30: 880-5.
42. Novakova L, Haluzik M, Jech R, Urgosik D, Ruzicka F, Ruzicka E. Hormonal regulators of food intake and weight gain in Parkinson's disease after subthalamic nucleus stimulation. Neuro Endocrinol Lett 2011; 32: 437-41.
43. Novakova L, Ruzicka E, Jech R, Serranova T, Dusek P, Urgosik D. Increase in body weight is a non-motor side effect of deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neuro Endocrinol Lett 2007; 28: 21-5.
44. Priori A, Cinnante C, Genitrini S, Pesenti A, Tortora G, Bencini C, et al. Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: preliminary physiological results. Neurol Sci 2001; 22: 85-6.
45. Robertson DR, Renwick AG, Macklin B, Jones S, Waller DG, George CF, et al. The influence of levodopa on gastric emptying in healthy elderly volunteers. Eur J Clin Pharmacol 1992; 42: 409-12.
46. Robertson DR, Renwick AG, Wood ND, Cross N, Macklin BS, Fleming JS, et al. The influence of levodopa on gastric emptying in man. Br J Clin Pharmacol 1990; 29: 47-53.
47. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005; 128 (Pt 10): 2240-9.
48. Rodriguez-Oroz MC, Zamarbide I, Guridi J, Palmero MR, Obeso JA. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 2004; 75: 1382-5.
49. Sakakibara R, Nakazawa K, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. Effects of subthalamic nucleus stimulation on the micturation reflex in cats. Neuroscience 2003; 120: 871-5.
50. Sanaka M, Nakada K. Stable isotope breath tests for assessing gastric emptying: a comprehensive review. J Smooth Muscle Res 2010; 46: 267-80.
51. Sanaka M, Yamamoto T, Kuyama Y. Retention, fixation, and loss of the [13C] label: a review for the understanding of gastric emptying breath tests. Dig Dis Sci 2008; 53: 1747-56.
52. Sauleau P, Leray E, Rouaud T, Drapier S, Drapier D, Blanchard S, et al. Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease. Mov Disord 2009; 24: 2149-55.
53. Schulte T, Brecht S, Herdegen T, Illert M, Mehdorn HM, Hamel W. Induction of immediate early gene expression by high-frequency stimulation of the subthalamic nucleus in rats. Neuroscience 2006; 138: 1377-85.
54. Schupbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1640-4.
55. Seif C, Herzog J, van der Horst C, Schrader B, Volkmann J, Deuschl G, et al. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol 2004; 55: 118-20.
56. Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease. Mov Disord 1997; 12: 952-7.
57. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007; 130 (Pt 6): 1596-607.
58. Stephan E, Pardo JV, Faris PL, Hartman BK, Kim SW, Ivanov EH, et al. Functional neuroimaging of gastric distention. J Gastrointest Surg 2003; 7: 740-9.
59. Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, et al. Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test. J Neurol 2011; 258: 421-6.
60. Thomaides T, Karapanayiotides T, Zoukos Y, Haeropoulos C, Kerezoudi E, Demacopoulos N, et al. Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease. J Neurol 2005; 252: 1055-9.
61. Valenzuela JE. Dopamine as a possible neurotransmitter in gastric relaxation. Gastroenterology 1976; 71: 1019-22.
62. Vandenbergh J, Dupont P, Fischler B, Bormans G, Persoons P, Janssens J, et al. Regional brain activation during proximal stomach distention in humans: A positron emission tomography study. Gastroenterology 2005; 128: 564-73.
63. Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 2002; 58: 396-401.
64. Witjas T, Kaphan E, Regis J, Jouve E, Cherif AA, Peragut JC, et al. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 2007; 22: 1729-34.
65. Zibetti M, Torre E, Cinquepalmi A, Rosso M, Ducati A, Bergamasco B, et al. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol 2007; 58: 218-23.